Literature DB >> 17510385

Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays.

Masanobu Takahashi1, Hideki Shimodaira, Corinne Andreutti-Zaugg, Richard Iggo, Richard D Kolodner, Chikashi Ishioka.   

Abstract

The functional characterization of nonsynonymous single nucleotide polymorphisms in human mismatch repair (MMR) genes has been critical to evaluate their pathogenicity for hereditary nonpolyposis colorectal cancer. We previously established an assay for detecting loss-of-function mutations in the MLH1 gene using a dominant mutator effect of human MLH1 expressed in Saccharomyces cerevisiae. The purpose of this study is to extend the functional analyses of nonsynonymous single nucleotide polymorphisms in the MLH1 gene both in quality and in quantity, and integrate the results to evaluate the variants for pathogenic significance. The 101 MLH1 variants, which covered most of the reported MLH1 nonsynonymous single nucleotide polymorphisms and consisted of one 3-bp deletion, 1 nonsense and 99 missense variants, were examined for the dominant mutator effect by three yeast assays and for the ability of the variant to repair a heteroduplex DNA with mismatch bases by in vitro MMR assay. There was diversity in the dominant mutator effects and the in vitro MMR activities among the variants. The majority of functionally inactive variants were located around the putative ATP-binding pocket of the NH(2)-terminal domain or the whole region of the COOH-terminal domain. Integrated functional evaluations contribute to a better prediction of the cancer risk in individuals or families carrying MLH1 variants and provide insights into the function-structure relationships in MLH1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510385     DOI: 10.1158/0008-5472.CAN-06-3509

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

1.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

Review 2.  Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome.

Authors:  Michael P Farrell; David J Hughes; Ian R Berry; David J Gallagher; Emily A Glogowski; Stewart J Payne; Michael J Kennedy; Róisín M Clarke; Susan A White; Cian B Muldoon; Fiona Macdonald; Pauline Rehal; Danielle Crompton; Solvig Roring; Sarah T Duke; Trudi McDevitt; David E Barton; Shirley V Hodgson; Andrew J Green; Peter A Daly
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.

Authors:  Patrizia Lastella; Margherita Patruno; Giovanna Forte; Alba Montanaro; Carmela Di Gregorio; Carlo Sabbà; Patrizia Suppressa; Adalgisa Piepoli; Anna Panza; Angelo Andriulli; Nicoletta Resta; Alessandro Stella
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy.

Authors:  Jenny Xie; Shawna Guillemette; Min Peng; Candace Gilbert; Andrew Buermeyer; Sharon B Cantor
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

5.  Making sense of missense in Lynch syndrome: the clinical perspective.

Authors:  Henry T Lynch; Thomas Jascur; Stephen Lanspa; C Richard Boland
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

6.  The MLH1 ATPase domain is needed for suppressing aberrant formation of interstitial telomeric sequences.

Authors:  Pingping Jia; Weihang Chai
Journal:  DNA Repair (Amst)       Date:  2018-03-07

7.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

8.  Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population.

Authors:  Mef Nilbert; Friedrik P Wikman; Thomas V O Hansen; Henrik B Krarup; Torben F Orntoft; Finn C Nielsen; Lone Sunde; Anne-Marie Gerdes; Dorthe Cruger; Susanne Timshel; Marie-Louise Bisgaard; Inge Bernstein; Henrik Okkels
Journal:  Fam Cancer       Date:  2008-06-20       Impact factor: 2.375

9.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

10.  Residues in the N-terminal domain of MutL required for mismatch repair in Bacillus subtilis.

Authors:  Nicholas J Bolz; Justin S Lenhart; Steven C Weindorf; Lyle A Simmons
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.